Cellares

Biotech · San Francisco, US

Cell therapy manufacturing company building automated Smart Factories.

Founders

Fabian Gerlinghaus (Germany · ♂) — An aerospace engineer by training and former Chief Innovation Officer at Synthego, he co-founded Cellares in 2019 to automate cell-therapy manufacturing so patients would not die waiting for life-saving treatments stuck in production bottlenecks.
Omar Kurdi (United States · ♂) — Co-founded Cellares in 2019 to build the first end-to-end automated platform for cell-therapy manufacturing and quality control.

Shares the most investors with (number = shared investors):

Date	Round	Amount
Jun 2026	Series D Plus ARK Invest added $20M to Cellares' Series D, bringing the round to $277M alongside BlackRock, Eclipse, T. Rowe Price and others, to scale cell-therapy Smart Factories.	$277M

Tap an investor to see what else they have backed.

Data is community-curated and may be incomplete.